Stanford’s AI Pipeline Uncovers BRP, an Appetite-Suppressing Peptide With a New Mechanism
Researchers at Stanford Medicine have used a computational screening pipeline to identify a naturally occurring peptide that curbs appetite in animals without the digestive side effects that make semaglutide — the active ingredient in Ozempic and Wegovy — difficult for some patients to tolerate. The molecule, a 12-amino-acid peptide dubbed BRP, was described in a … Read more